Combinations of therapeutic agents for treating cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/352 (2006.01) A61K 31/4188 (2006.01) A61K 31/425 (2006.01) A61K 31/4745 (2006.01) A61K 31/517 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2708149

The invention relates to a combination comprising vascular disrupting agent (VDA), such as 5,6-dimethylxanthenone-4-acetic acid or a pharmaceutically acceptable salt, ester or prodrug thereof; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.

L'invention concerne une combinaison qui comprend un VDA (vascular disrupting agent) tel que l'acide 5,6-diméthylxanthénone-4-acétique ou un de ses sels pharmaceutiquement acceptables, esters ou promédicaments ; et un ou plusieurs agents pharmaceutiquement actifs ; des compositions pharmaceutiques comprenant ladite combinaison ; des procédés de traitement comprenant ladite combinaison ; des procédés de fabrication de ladite combinaison ; et un emballage commercial comprenant ladite combinaison.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combinations of therapeutic agents for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations of therapeutic agents for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of therapeutic agents for treating cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1827465

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.